Teladoc Health, Inc. Financial Ratios — TDOC Stock

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-28.58	-36.08	-27.83	-18.93	-8.25	-6.31	-5.01	-2.42	-123.73	-5.04	-25.32	-6.28
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	78.97	77.19	72.81	74.04	73.58	69.2	66.66	64.27	68.01	69.09	70.8	70.76	69.5
EBITDA Margin (%)	-25.7	-29.02	-65.09	-38.52	-18.48	-7.27	-5.22	-31.09	-0.95	1.68	5.31	6.77	8.42
Operating Margin (%)	-29.48	-34.35	-71.38	-45.23	-26.66	-15.78	-13.34	-38.23	-11.76	-9.45	-8.09	-8.13	-6.46
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-29.76	-38.25	-74.93	-59.85	-45.87	-23.2	-19.78	-52.65	-18.92	-567.69	-8.44	-38.67	-9.31
Profit Margin (%)	-30.24	-39.14	-74.98	-60.26	-45.77	-23.23	-17.87	-44.35	-21.09	-567.53	-8.47	-38.97	-7.92
Net Income to Common Margin (%)	-49.43	-46.23	-74.98	-60.26	-45.77	-23.23	-17.87	-44.35	-21.09	-567.53	-8.47	-38.97	-7.92
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	38.83	15.34	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	3	26	26	44	207	415	470	1,477	1,280	1,587	1,592	1,585	1,040
ST Debt	- -	1	1	2	- -	- -	5	54	13	14	11	561	11
LT Debt	3	25	25	42	207	415	465	1,423	1,267	1,573	1,582	1,024	1,029
Total Debt/EBITDA	-0.59	-2.05	-0.53	-0.94	-4.81	-13.66	-16.3	-4.34	-66.1	39.26	11.52	9.1	4.88
Net Debt/EBITDA	0.04	1.63	0.57	0.12	-3.82	0.31	2.56	-2.03	-17.15	15.27	3	1.4	1
Total Debt/EBIT	-0.51	-1.73	-0.48	-0.8	-3.33	-6.29	-6.37	-3.53	-5.36	-6.98	-7.56	-7.59	-6.37
Net Debt/EBIT	0.04	1.38	0.52	0.1	-2.65	0.14	1	-1.65	-1.39	-2.71	-1.97	-1.17	-1.31
EBITDA to Interest Expense	-91.34	-8.43	-22.91	-18.33	-2.46	-1.16	-0.98	-5.67	-0.24	1.84	6.2	7.31	10.81
EBITDA-CapEx/Interest Expense	-114.45	-9.59	-26.46	-19.65	-2.78	-1.48	-1.35	-6.04	-0.92	1.84	6.2	7.31	9.31
EBIT to Interest Expense	-104.8	-9.98	-25.12	-21.52	-3.56	-2.53	-2.51	-6.98	-2.95	-10.36	-9.45	-8.77	-8.29
Interest Expense	- -	1	2	3	17	26	29	60	81	22	22	24	20
Common Equity/Total Assets	-192.07	-75.82	-56.79	-67.4	-37.79	-26.72	-31.66	-5.59	-8.01	-345.38	-346.7	-461.53	-574.82
Long-Term Debt/Equity (%)	15.74	47.04	14.13	18.38	37.1	40.93	45.9	8.96	7.9	68.18	67.99	68.65	74.27
Long-Term Debt/Capital (%)	13.6	33.77	-24.26	-26.47	-199.11	6,807.01	-1,259.21	293.82	-897.86	-11.72	-11.6	-6.99	-6.69
Long-Term Debt/Total Assets (%)	10.95	27.27	10.98	13.97	25.15	27.12	29.04	8.01	7.15	36.21	36.01	29.11	36
Total Debt/Equity (%)	15.74	48.61	14.83	19.24	37.1	40.93	46.4	9.3	7.98	68.77	68.45	106.27	75.06
Total Debt/Capital (%)	13.6	34.89	-25.46	-27.72	-199.11	6,807.01	-1,272.98	304.97	-906.85	-11.82	-11.68	-10.82	-6.76
Total Debt/Total Assets (%)	10.95	28.17	11.52	14.63	25.15	27.12	29.35	8.32	7.22	36.52	36.25	45.06	36.39
Net Debt to Equity	-1.11	-38.63	-16.01	-2.42	29.44	-0.92	-7.29	4.34	2.07	26.74	17.84	16.35	15.43
Net Debt/Capital (%)	-1.13	-74.19	17.97	2.66	-111.97	2.23	13.41	-276.52	-32.11	-4.3	-2.81	-1.53	-1.32
EBITDA	-5	-13	-50	-47	-43	-30	-29	-340	-19	40	138	174	213
EBITDA-CapEx	-6	-14	-58	-51	-49	-39	-40	-362	-75	40	138	174	183
Operating Income (Loss)	-6	-15	-55	-56	-62	-66	-74	-418	-239	-227	-211	-209	-163

Liquidity (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.62	4.5	7.64	3.12	3.03	7.66	5.73	2.36	2.71	2.3	2.67	1.38	1.93
Current Ratio	1.33	5.28	8.43	3.93	3.87	8.53	6.52	3.19	3.7	3.29	3.54	1.77	2.77
Quick Ratio	1.18	5.19	8.31	3.78	3.7	8.36	6.37	2.87	3.28	2.89	3.22	1.62	2.43
CFO/Avg Current Liab	- -	-1.47	-3.33	-2.66	-1.12	-0.09	0.39	-0.25	0.58	0.52	0.85	0.43	0.44
Common Equity/Total Assets	-192.07	-75.82	-56.79	-67.4	-37.79	-26.72	-31.66	-5.59	-8.01	-345.38	-346.7	-461.53	-574.82
Long-Term Debt/Equity (%)	15.74	47.04	14.13	18.38	37.1	40.93	45.9	8.96	7.9	68.18	67.99	68.65	74.27
Long-Term Debt/Capital (%)	13.6	33.77	-24.26	-26.47	-199.11	6,807.01	-1,259.21	293.82	-897.86	-11.72	-11.6	-6.99	-6.69
Long-Term Debt/Total Assets (%)	10.95	27.27	10.98	13.97	25.15	27.12	29.04	8.01	7.15	36.21	36.01	29.11	36
Total Debt/Equity (%)	15.74	48.61	14.83	19.24	37.1	40.93	46.4	9.3	7.98	68.77	68.45	106.27	75.06
Total Debt/Capital (%)	13.6	34.89	-25.46	-27.72	-199.11	6,807.01	-1,272.98	304.97	-906.85	-11.82	-11.68	-10.82	-6.76
Total Debt/Total Assets (%)	10.95	28.17	11.52	14.63	25.15	27.12	29.35	8.32	7.22	36.52	36.25	45.06	36.39
CFO/Total Liabilities	-72.66	-29.42	-92.2	-71.26	-12.97	-0.94	5.07	-2.86	11.49	9.29	16.94	14.5	19.99
CFO/CapEx	-4.68	-6.55	-6.04	-15.2	-6.24	-0.58	2.74	-2.43	3.5	- -	- -	- -	9.95
Altman's Z-Score	-10.36	-0.97	3.39	2.74	2.75	4.15	6.44	5.11	5.37	-11.59	-10.03	-10.63	-15.27

Working Capital (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	9.21	8.16	9.5	11.41	11.83	11.01	9.67	12.02	12.68	12.16	11.91	12.43
Days Sales Outstanding	- -	39.62	44.75	38.44	32	30.86	33.15	37.74	30.37	28.78	30.01	30.65	29.36
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	13.84	10.04	11.5	17.7	22.21	20.21
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	26.38	36.37	31.75	20.62	16.43	18.06
Accounts Payable Turnover	- -	8.72	9.51	14.37	20.14	22.09	21.9	16.24	14.3	15.32	16.06	19.8	19.03
Accounts Payable Turnover Days	- -	41.85	38.36	25.4	18.12	16.52	16.66	22.48	25.53	23.83	22.73	18.44	19.18
Cash Conversion Cycle	- -	-2.24	6.38	13.04	13.87	14.34	16.49	41.64	41.2	36.7	27.9	28.65	28.23
Inventory to Cash Days	- -	39.62	44.75	38.44	32	30.86	33.15	11.36	-6	-2.97	9.4	14.22	11.3
Inventories	- -	- -	- -	- -	- -	- -	- -	56	73	56	30	38	38
Raw Materials	- -	- -	- -	- -	- -	- -	- -	20	29	26	9	14	14
Work In Process	- -	- -	- -	- -	- -	- -	- -	1	1	- -	- -	1	1
Finished Goods	- -	- -	- -	- -	- -	- -	- -	35	49	30	20	23	24
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	6	- -	- -	- -

Enterprise Value (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	358	698	1,932	3,264	6,015	18,098	14,410	3,818	3,495	1,550	1,234
- Cash & Cash Equivalents	3	46	55	50	43	424	514	733	893	918	1,124	1,298	781
+ Preferred Equity and Hybrid Capital	72	118	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	3	26	26	44	207	415	470	1,477	1,280	1,587	1,592	1,585	1,040
Enterprise Value	71	97	247	677	2,017	3,200	5,968	18,788	14,794	4,487	3,963	1,837	1,493
Total Capital	22	74	-104	-160	-104	6	-37	484	-141	-13,421	-13,636	-14,645	-15,390
Total Debt/Capital (%)	13.6	34.89	-25.46	-27.72	-199.11	6,807.01	-1,272.98	304.97	-906.85	-11.82	-11.68	-10.82	-6.76
Total Debt / EV	0.04	0.27	0.11	0.07	0.1	0.13	0.08	0.08	0.09	0.35	0.4	0.86	0.7
EV/Sales	3.59	2.24	3.19	5.5	8.65	7.66	10.79	17.17	7.28	1.86	1.52	0.71	0.59
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	111.02	28.67	10.55	7.01
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	150.35	105.85	- -	52.01	21.24	10.64	5.78	4.8
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	107.78	88.7	988.84	43.53	21.24	10.64	5.78	4.38
Diluted Market Cap	- -	- -	358	698	1,932	3,264	6,015	18,098	14,410	3,818	3,495	1,550	1,234
Diluted Enterprise Value	71	97	329	693	2,096	3,255	5,971	18,842	14,797	4,487	3,963	1,837	1,493
EV per Share	0.47	0.64	12.39	15.99	36.38	48.6	83.07	207.59	94.27	27.79	24.44	10.77	8.47
TTM Sales	20	44	77	123	233	418	553	1,094	2,033	2,407	2,602	2,570	2,530
TTM EBITDA	-5	-13	-50	-47	-43	-30	-29	-340	-19	40	138	174	213
TTM Operating Income	-6	-15	-55	-56	-62	-66	-74	-418	-239	-227	-211	-209	-163
TTM Cash Flow to Firm	-6	-10	-45	-49	-17	21	56	-3	284	211	372	318	311
TTM Free Cash Flow to Firm	-5	-8	-37	-46	-11	30	67	19	340	211	372	318	341

Multiples (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-9.09	-14.41	-66.78	920.2	147.53	-574.67	57.78	20.17	9.98	5.28	3.81
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	71	97	247	677	2,017	3,200	5,968	18,788	14,794	4,487	3,963	1,837	1,493
Low Price	- -	- -	15.32	9.08	15.65	30.88	46	81.3	87.27	22.35	15.02	6.76	6.35
EV/Sales	3.59	2.24	3.19	5.5	8.65	7.66	10.79	17.17	7.28	1.86	1.52	0.71	0.59
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	111.02	28.67	10.55	7.01
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-7.79	-8.61	-15.06	-37.22	-47.52	-33.05	-60.02	-0.52	-17.23	-2.04	-7.24
Price/Earnings High	- -	- -	-12.16	-11.86	-19.67	-60.39	-62.71	-47.2	-112.73	-1.13	-25.29	-3.84	-13.38
Price/Earnings Low	- -	- -	-5.26	-5.18	-8.12	-20.94	-33.43	-15.17	-31.94	-0.26	-11.05	-1.15	-5.59
Price/Book Value	- -	- -	-2.74	-3.41	-6.2	-7.99	-11.85	-18.23	-10.14	-0.25	-0.23	-0.1	-0.08
Price/Book Value Average	- -	- -	-3.47	-3.12	-5.16	-8.84	-9.26	-16.16	-18.11	-0.47	-0.25	-0.13	-0.09
Price/Book Value High	- -	- -	-5.41	-4.3	-6.74	-14.35	-12.22	-23.07	-34.01	-1.03	-0.37	-0.24	-0.16
Price/Book Value Low	- -	- -	-2.34	-1.88	-2.78	-4.98	-6.51	-7.41	-9.64	-0.24	-0.16	-0.07	-0.07
Price/Tangible Book Value	- -	- -	3.34	39.22	-19.43	114.41	141.55	-25.2	-39.08	-6.34	-8.22	-6.94	-6.34
Price/Tangible Book Value Average	- -	- -	4.23	35.89	-16.18	126.66	110.56	-22.32	-69.8	-11.8	-8.93	-9.16	-7.45
Price/Tangible Book Value High	- -	- -	6.6	49.43	-21.13	205.53	145.91	-31.88	-131.1	-25.66	-13.11	-17.2	-13.78
Price/Tangible Book Value Low	- -	- -	2.85	21.58	-8.72	71.26	77.77	-10.24	-37.15	-5.99	-5.73	-5.16	-5.75
Price/Sales	- -	- -	4.62	5.67	8.28	7.81	10.87	16.54	7.09	1.59	1.34	0.6	0.49
Price/Sales Average	- -	- -	5.84	5.19	6.89	8.65	8.49	14.66	12.66	2.95	1.46	0.8	0.57
Price/Sales High	- -	- -	9.12	7.15	9.01	14.03	11.21	20.93	23.78	6.42	2.14	1.5	1.06
Price/Sales Low	- -	- -	3.94	3.12	3.72	4.86	5.97	6.73	6.74	1.5	0.94	0.45	0.44
Price/Cash Flow	- -	- -	-7.58	-13.46	-56.09	-671.59	201.37	-338.22	74.28	20.17	9.98	5.28	4.19
Price/Cash Flow Average	- -	- -	-9.58	-12.32	-46.7	-743.46	157.29	-299.64	132.66	37.53	10.85	6.97	4.93
Price/Cash Flow High	- -	- -	-14.95	-16.97	-60.99	-1,206.43	207.58	-427.93	249.17	81.64	15.92	13.09	9.11
Price/Cash Flow Low	- -	- -	-6.47	-7.41	-25.19	-418.3	110.64	-137.51	70.6	19.06	6.96	3.93	3.8
Price/Free Cash Flow Average	- -	- -	-11.49	-13.19	-55.6	1,018.67	115.23	-509.13	103.19	37.53	10.85	6.97	4.48
Price/Free Cash Flow High	- -	- -	-17.92	-18.17	-72.62	1,653.01	152.08	-727.11	193.82	81.64	15.92	13.09	8.27
Price/Free Cash Flow Low	- -	- -	-7.75	-7.93	-29.99	573.15	81.06	-233.65	54.92	19.06	6.96	3.93	3.45
EV/Sales Average	3.59	2.24	5.47	5.14	7.6	8.62	8.41	15.34	12.85	3.23	1.64	0.91	0.68
EV/Sales High	3.59	2.24	8.75	7.1	9.71	14.01	11.13	21.61	23.97	6.7	2.32	1.61	1.16
EV/Sales Low	3.59	2.24	3.57	3.08	4.42	4.84	5.89	7.41	6.93	1.78	1.12	0.56	0.54
EV/EBITDA Average	-13.97	-7.71	-8.41	-13.36	-41.13	-118.7	-161.21	-49.33	-1,348.8	192.31	30.86	13.4	8.02
EV/EBITDA High	-13.97	-7.71	-13.44	-18.44	-52.55	-192.81	-213.24	-69.52	-2,515.82	398.88	43.7	23.73	13.8
EV/EBITDA Low	-13.97	-7.71	-5.49	-7.99	-23.94	-66.65	-112.95	-23.82	-727.15	105.83	21.01	8.27	6.47
EV/EBIT Average	-12.17	-6.51	-7.67	-11.37	-28.5	-54.64	-63.04	-40.12	-109.3	-34.19	-20.26	-11.17	-10.46
EV/EBIT High	-12.17	-6.51	-12.25	-15.71	-36.42	-88.75	-83.39	-56.54	-203.88	-70.91	-28.7	-19.78	-17.99
EV/EBIT Low	-12.17	-6.51	-5.01	-6.8	-16.59	-30.68	-44.17	-19.37	-58.93	-18.81	-13.8	-6.89	-8.43
Last Price	- -	- -	17.96	16.5	34.85	49.57	83.72	199.96	91.82	23.65	21.55	9.09	7
High Price	- -	- -	35.42	20.8	37.9	89.05	86.3	253	308	95.71	34.36	22.54	15.21
Enterprise Value Average	71	97	424	634	1,773	3,604	4,654	16,778	26,122	7,773	4,265	2,332	1,709
Enterprise Value High	71	97	677	875	2,265	5,854	6,156	23,642	48,724	16,122	6,041	4,131	2,939
Enterprise Value Low	71	97	277	379	1,032	2,024	3,261	8,102	14,083	4,277	2,904	1,439	1,378

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	36	36	39	46	62	71	73	150	160	163	167	173	178
Diluted Weighted Avg Shares	152	152	20	42	55	66	72	91	157	161	162	171	176
Basic Weighted Avg Shares	152	152	20	42	55	66	72	91	157	161	162	171	176
Revenue per Share	0.13	0.29	3.89	2.91	4.21	6.35	7.7	12.09	12.95	14.91	16.05	15.07	14.36
EBITDA per Share	-0.03	-0.08	-2.53	-1.12	-0.78	-0.46	-0.4	-3.76	-0.12	0.25	0.85	1.02	1.21
Operating Income per Share	-0.04	-0.1	-2.77	-1.32	-1.12	-1	-1.03	-4.62	-1.52	-1.41	-1.3	-1.22	-0.93
Basic EPS, GAAP	-0.06	-0.13	-2.91	-1.75	-1.93	-1.47	-1.38	-5.36	-2.73	-84.6	-1.36	-5.87	-1.14
Basic EPS from Cont Ops	-0.04	-0.11	-2.91	-1.75	-1.93	-1.47	-1.38	-5.36	-2.73	-84.6	-1.36	-5.87	-1.14
Diluted EPS, GAAP	-0.06	-0.13	-2.91	-1.75	-1.93	-1.47	-1.38	-5.36	-2.73	-84.6	-1.36	-5.87	-1.14
Diluted EPS from Cont Ops	-0.04	-0.11	-2.91	-1.75	-1.93	-1.47	-1.38	-5.36	-2.73	-84.6	-1.36	-5.87	-1.14
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.04	-0.07	-2.37	-1.23	-0.62	-0.07	0.42	-0.59	1.24	1.17	2.16	1.72	1.67
Free Cash Flow per Basic Share	-0.05	-0.09	-2.76	-1.31	-0.72	-0.2	0.26	-0.83	0.88	1.17	2.16	1.72	1.5
Cash & Equivalents per Share	0.02	0.31	6.9	1.55	2.21	7.27	7.2	8.69	5.71	5.69	6.93	7.61	4.43
Book Value per Share	-0.35	-0.46	-6.55	-4.84	-5.62	-6.21	-7.06	-10.97	-9.06	-92.95	-93.9	-95.15	-93.24
Tangible Book Value per Share	-0.48	-0.66	5.37	0.42	-1.79	0.43	0.59	-7.94	-2.35	-3.73	-2.62	-1.31	-1.1

Teladoc Health, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)